Biocon's core R&D philosophy of making high quality affordable medicines is centred on a 'credibly capable' matrix. In pursuit of our objective of enhancing global healthcare through innovative and affordable biopharmaceuticals, Biocon's Research and Development (R&D) function has built world-class competence and capability on the back of robust infrastructure and a talent pool that has extensive global product development experience.

R&D's core strategy is based on integrated discovery, stage gated approach to development, core disease area expertise (autoimmune and inflammation, oncology and diabetes), and a first-rate scientific advisory board. The R&D organization has four essential elements in its strategy: Enable, Business, Talent and Culture.